Africa strikes deal with Pfizer for Covid-19 antiviral — report
As the FDA looks to make Pfizer’s Covid-19 antiviral more accessible in the US, Africa’s CDC has reportedly struck an agreement with the pharma giant to increase supplies across the continent.
The health agency has reached a memorandum of understanding with Pfizer which will allow African countries to access Paxlovid at cost, according to a Reuters report.
The news comes just a few months after researchers with the Drugs for Neglected Diseases Initiative reported that they were denied access to Paxlovid for use in a large study in 10 African countries in a variety of settings and in some combinations with other therapies. Pfizer allegedly told the researchers that it already had plans to conduct similar trials, according to a Nature report.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
